These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23261793)

  • 21. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.
    Chavez AO; Molina-Carrion M; Abdul-Ghani MA; Folli F; Defronzo RA; Tripathy D
    Diabetes Care; 2009 Aug; 32(8):1542-6. PubMed ID: 19487637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance and beta-cell dysfunction in people with prediabetes according to criteria based on glycemia and glycosylated hemoglobin.
    Tura A; Göbl C; Moro E; Pacini G
    Endocr J; 2017 Jan; 64(1):117-122. PubMed ID: 27628439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research).
    Yang G; Li C; Gong Y; Fang F; Tian H; Li J; Cheng X
    J Diabetes Res; 2016; 2016():9270768. PubMed ID: 26770991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
    de Jesús Garduno-Garcia J; Gastaldelli A; DeFronzo RA; Lertwattanarak R; Holst JJ; Musi N
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2613-2619. PubMed ID: 29672742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determining pancreatic β-cell compensation for changing insulin sensitivity using an oral glucose tolerance test.
    Solomon TP; Malin SK; Karstoft K; Knudsen SH; Haus JM; Laye MJ; Pedersen M; Pedersen BK; Kirwan JP
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E822-9. PubMed ID: 25184989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Habitual Daily Physical Activity With Glucose Tolerance and β-Cell Function in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes From the Restoring Insulin Secretion (RISE) Study.
    Temple KA; Tjaden AH; Atkinson KM; Barengolts E; Hannon TS; Mather KJ; Utzschneider KM; Edelstein SL; Ehrmann DA; Mokhlesi B;
    Diabetes Care; 2019 Aug; 42(8):1521-1529. PubMed ID: 31177181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.
    Marini MA; Fiorentino TV; Andreozzi F; Mannino GC; Perticone M; Sciacqua A; Perticone F; Sesti G
    Acta Diabetol; 2017 Aug; 54(8):775-784. PubMed ID: 28577138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethnic differences in insulin sensitivity, β-cell function, and hepatic extraction between Japanese and Caucasians: a minimal model analysis.
    Møller JB; Dalla Man C; Overgaard RV; Ingwersen SH; Tornøe CW; Pedersen M; Tanaka H; Ohsugi M; Ueki K; Lynge J; Vasconcelos NM; Pedersen BK; Kadowaki T; Cobelli C
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4273-80. PubMed ID: 25119313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between serum secreted frizzled-related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance.
    Liu F; Qu H; Li Y; Tang Q; Yang Z; Wang H; Deng H
    Endocr J; 2015; 62(8):733-40. PubMed ID: 26041556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active and passive exposure to tobacco smoke in relation to insulin sensitivity and pancreatic β-cell function in Japanese subjects.
    Oba S; Suzuki E; Yamamoto M; Horikawa Y; Nagata C; Takeda J;
    Diabetes Metab; 2015 Apr; 41(2):160-7. PubMed ID: 25451187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of reduced β-cell function in Asian Indians with mild dysglycemia.
    Staimez LR; Weber MB; Ranjani H; Ali MK; Echouffo-Tcheugui JB; Phillips LS; Mohan V; Narayan KM
    Diabetes Care; 2013 Sep; 36(9):2772-8. PubMed ID: 23596180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
    Salinitri FD; Pinelli NR; Martin ET; Jaber LA
    Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
    Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
    Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The homeostasis model in the San Antonio Heart Study.
    Haffner SM; Miettinen H; Stern MP
    Diabetes Care; 1997 Jul; 20(7):1087-92. PubMed ID: 9203442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes.
    Fukushima M; Usami M; Ikeda M; Nakai Y; Taniguchi A; Matsuura T; Suzuki H; Kurose T; Yamada Y; Seino Y
    Metabolism; 2004 Jul; 53(7):831-5. PubMed ID: 15254872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The usefulness of basal blood glucose and glycosylated hemoglobin for the detection of abnormal glucose tolerance in the relatives of patients with type-2 diabetes mellitus].
    Costa A; Conget I; Treserras R; Gomis R
    Med Clin (Barc); 1999 Feb; 112(7):241-4. PubMed ID: 10220749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.